Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T16:27:28.062Z.
Consensus retrieved: 2026-10-06T13:26:43.384Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T16:27:28.062Z.
Quote observation: 2026-10-06T16:04:47.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f6adff8253f4c85dc5eb0f5c76b7f284768243a99251a0912c87940a98678e1d
Forward PE Ratio (N/A) = Dated Quote Price ($6.16) / Consensus Forward EPS ($-5.70)
FORWARD PE RATIO
N/A
Lifeward Ltd.
Market Cap
$9.92M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Lifeward Ltd. (LFWD) | $9.92M | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.05M | N/A |
| MetaVia Inc. (MTVA)vs › | $10.08M | N/A |
| Ainos, Inc. (AIMD)vs › | $9.72M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.66M | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.44M | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.37M | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.47M | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.33M | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.64M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $6.16, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-5.70 | $-5.97 – $-5.43 | 1 | n/m |
| 2027-12-31 | $-1.35 | $-1.41 – $-1.29 | 1 | n/m |
| 2028-12-31 | $-0.54 | $-0.71 – $-0.37 | 2 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
